Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
Acta Biomaterialia
|
November 24, 2022
Scaffold-based tissue engineering: Supercritical carbon dioxide as an alternative method for decellularization and sterilization of dense materials
R J J de Wit, D J van Dis, M E Bertrand, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
September 17, 2017
Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma
S de Groot, W K Redekop, M M Versteegh, et al.
The Journal of Urology
|
January 13, 2006
A clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin-2 pulsing scheme for advanced renal cell carcinoma
I Bleumer, E Oosterwijk, J C Oosterwijk-Wakka, et al.
BMC Cancer
|
June 12, 2016
Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry
S De Groot, S Sleijfer, W K Redekop, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinoma
T Shimazui, E Oosterwijk, H Akaza, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 5, 2011
Better survival in patients with metastasised kidney cancer after nephrectomy: a population-based study in the Netherlands
K K H Aben, S Heskamp, M L Janssen-Heijnen, et al.
The American Journal of Pathology
|
May 1, 1986
Immunohistochemical analysis of monoclonal antibodies to renal antigens. Application in the diagnosis of renal cell carcinoma
E Oosterwijk, D J Ruiter, J C Wakka, et al.
Nuclear Medicine Communications
|
March 14, 2002
131 I-cG250 monoclonal antibody immunoscintigraphy versus [18 F]FDG-PET imaging in patients with metastatic renal cell carcinoma: a comparative study
A H Brouwers, U Dorr, O Lang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1993
Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250
E Oosterwijk, N H Bander, C R Divgi, et al.
Cancer Research
|
September 15, 1999
Pretargeting of renal cell carcinoma: improved tumor targeting with a bivalent chelate
O C Boerman, M H Kranenborg, E Oosterwijk, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
Acta Biomaterialia
|
November 24, 2022
Scaffold-based tissue engineering: Supercritical carbon dioxide as an alternative method for decellularization and sterilization of dense materials
R J J de Wit, D J van Dis, M E Bertrand, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
September 17, 2017
Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma
S de Groot, W K Redekop, M M Versteegh, et al.
The Journal of Urology
|
January 13, 2006
A clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin-2 pulsing scheme for advanced renal cell carcinoma
I Bleumer, E Oosterwijk, J C Oosterwijk-Wakka, et al.
BMC Cancer
|
June 12, 2016
Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry
S De Groot, S Sleijfer, W K Redekop, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinoma
T Shimazui, E Oosterwijk, H Akaza, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 5, 2011
Better survival in patients with metastasised kidney cancer after nephrectomy: a population-based study in the Netherlands
K K H Aben, S Heskamp, M L Janssen-Heijnen, et al.
The American Journal of Pathology
|
May 1, 1986
Immunohistochemical analysis of monoclonal antibodies to renal antigens. Application in the diagnosis of renal cell carcinoma
E Oosterwijk, D J Ruiter, J C Wakka, et al.
Nuclear Medicine Communications
|
March 14, 2002
131 I-cG250 monoclonal antibody immunoscintigraphy versus [18 F]FDG-PET imaging in patients with metastatic renal cell carcinoma: a comparative study
A H Brouwers, U Dorr, O Lang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1993
Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250
E Oosterwijk, N H Bander, C R Divgi, et al.
Cancer Research
|
September 15, 1999
Pretargeting of renal cell carcinoma: improved tumor targeting with a bivalent chelate
O C Boerman, M H Kranenborg, E Oosterwijk, et al.
Page
of 8